Clinical trial
A Study of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With…
NCT00246025 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00246025 |
|---|---|
| Title | A Study of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With TKR Surgery. |
| Official title | A Randomised, Parallel-group, Double-blind, Placebo Controlled Study to Investigate the Efficacy and Safety of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Knee Replacement Surgery |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Arthroplasty, Replacement, Knee, Venous Thrombosis |
| Intervention type | Drug |
| Interventions | Dabigatran etexilate, Dabigatran Etexilate, placebo |
| Enrollment | 512 |
| Start date | Oct 1, 2005 |
| Primary completion | Jun 1, 2007 |
| First posted | Oct 31, 2005 |
| Last update posted | Jun 9, 2014 |
| Countries | Japan |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: